English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

ISH for SSTR2 mRNA was performed using the RNAscope 2.0 FFPE Assay (Advanced Cell Diagnostics, Inc., Hayward, CA, USA) on 4-μm formalin fixed and paraffin embedded tissue sections. After deparaffinization they were pretreated with heat and protease prior to hybridization with a target probe to the SSTR2. A horseradish peroxidase-based signal amplification system was then hybridized to the target probes followed by color development with 3,3 -diaminobenzidine. Control probes for the bacterial gene DapB (negative control) and for the POLR2A gene (positive control – evidence of adequate RNA) were also included in each case. The study slides (and corresponding controls) were read independently by two study pathologists (A.K. and J.L) and classified in a binary manner as either positive or negative. Positive cases had to have granular cytoplasmic and/or nuclear brown staining that was higher than the signal on the DapB negative control slide. Positive cases were subsequently semi-quantitatively assessed according to the manufacturer s scoring guideline as follows: Methods

endocrine abstracts

No correlation between somatostatine 2 receptor expression analyzed by RNA<i>in-situ</i>hybridization and real-time qRT-PCR in clinically non-functioning pituitary adenomas

No correlation between somatostatine 2 receptor expression analyzed by RNAin-situhybridization and real-time qRT-PCR in clinically non-functioning pituitary adenomas